4.7 Article

Clinical effect and antiviral mechanism of T-705 in treating severe fever with thrombocytopenia syndrome

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Microbiology

Lethal Mutagenesis of Rift Valley Fever Virus Induced by Favipiravir

Belen Borrego et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)

Letter Infectious Diseases

The pitfall of cohort isolation in an outbreak of linezolid-resistant, vancomycin-resistant enterococci

J. Jung et al.

CLINICAL MICROBIOLOGY AND INFECTION (2019)

Letter Immunology

Severe Fever with Thrombocytopenia Syndrome Virus RNA in Semen, Japan

Satoru Koga et al.

EMERGING INFECTIOUS DISEASES (2019)

Letter Immunology

Endemic Severe Fever with Thrombocytopenia Syndrome, Vietnam

Xuan Chuong Tran et al.

EMERGING INFECTIOUS DISEASES (2019)

Review Pharmacology & Pharmacy

Favipiravir as a potential countermeasure against neglected and emerging RNA viruses

Leen Delang et al.

ANTIVIRAL RESEARCH (2018)

Article Medicine, General & Internal

Antiviral efficacy of favipiravir against Ebola virus: A translational study in cynomolgus macaques

Jeremie Guedj et al.

PLOS MEDICINE (2018)

Letter Medicine, General & Internal

Mutagenesis in Norovirus in Response to Favipiravir Treatment

Christopher Ruis et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Biochemistry & Molecular Biology

Evidence for the Selective Basis of Transition-to-Transversion Substitution Bias in Two RNA Viruses

Daniel M. Lyons et al.

MOLECULAR BIOLOGY AND EVOLUTION (2017)

Article Infectious Diseases

Favipiravir pharmacokinetics in Ebola-infected patients of the JIKI trial reveals concentrations lower than targeted

Thi Huyen Tram Nguyen et al.

PLOS NEGLECTED TROPICAL DISEASES (2017)

Article Microbiology

Distinct Effects of T-705 (Favipiravir) and Ribavirin on Influenza Virus Replication and Viral RNA Synthesis

Evelien Vanderlinden et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)

Letter Infectious Diseases

Dose regimen of favipiravir for Ebola virus disease

France Mentre et al.

LANCET INFECTIOUS DISEASES (2015)

News Item Multidisciplinary Sciences

INFECTIOUS DISEASES Ebola drug trials lurch ahead

Kai Kupferschmidt et al.

SCIENCE (2015)

Article Immunology

Novel Phlebovirus with Zoonotic Potential Isolated from Ticks, Australia

Jianning Wang et al.

EMERGING INFECTIOUS DISEASES (2014)

Article Microbiology

Mechanism of Action of T-705 Ribosyl Triphosphate against Influenza Virus RNA Polymerase

Hidehiro Sangawa et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)

Article Immunology

Severe Fever with Thrombocytopenia Syndrome, South Korea, 2012

Kye-Hyung Kim et al.

EMERGING INFECTIOUS DISEASES (2013)

Article Medicine, General & Internal

A New Phlebovirus Associated with Severe Febrile Illness in Missouri

Laura K. McMullan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Microbiology

T-705 (Favipiravir) Inhibition of Arenavirus Replication in Cell Culture

Michelle Mendenhall et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)

Article Medicine, General & Internal

Fever with Thrombocytopenia Associated with a Novel Bunyavirus in China

Xue-Jie Yu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Pharmacology & Pharmacy

Efficacy of favipiravir (T-705) and T-1106 pyrazine derivatives in phlebovirus disease models

Brian B. Gowen et al.

ANTIVIRAL RESEARCH (2010)

Article Biochemical Research Methods

The Sequence Alignment/Map format and SAMtools

Heng Li et al.

BIOINFORMATICS (2009)

Article Pharmacology & Pharmacy

Efficacy of orally administered T-705 pyrazine analog on lethal West Nile virus infection in rodents

John D. Morrey et al.

ANTIVIRAL RESEARCH (2008)

Article Microbiology

In vitro and in vivo activities of T-705 against arenavirus and bunyavirus infections

Brian B. Gowen et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)

Article Microbiology

Mechanism of action of T-705 against influenza virus

Y Furuta et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)